Does plaquinol (hydroxychloroquine) increase potassium levels, potentially leading to hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Hydroxychloroquine (Plaquenil) does not typically increase potassium levels or cause hyperkalemia. This medication, commonly used for autoimmune conditions like rheumatoid arthritis and lupus, as well as for malaria prevention, does not directly affect potassium regulation in the body. Hyperkalemia (high potassium levels) is not listed among the known side effects of hydroxychloroquine. The medication primarily works by reducing inflammation and modulating immune responses, rather than affecting electrolyte balance.

However, patients with severe kidney disease taking hydroxychloroquine should be monitored more carefully, as impaired kidney function can independently lead to potassium retention, as discussed in a study on hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers 1. If you're concerned about potassium levels while taking hydroxychloroquine, regular blood tests can monitor electrolyte levels, but specific potassium monitoring is not routinely required solely due to hydroxychloroquine use.

Other medications like certain diuretics, ACE inhibitors, and potassium supplements are much more commonly associated with hyperkalemia, as highlighted in a review of pharmacologic treatment of chronic hyperkalemia in patients with chronic kidney disease 2. Additionally, a study on the diagnosis and treatment of hyperkalemia notes that hyperkalemia can result from the shift of potassium out of cells or from abnormal renal potassium excretion, but hydroxychloroquine is not mentioned as a contributing factor 3.

In terms of management, it's essential to consider the patient's overall clinical context, including any underlying kidney disease or use of other medications that may affect potassium levels, as emphasized in a review of hyperkalemia: pathophysiology, risk factors, and consequences 4.

Key points to consider:

  • Hydroxychloroquine does not directly affect potassium regulation
  • Patients with severe kidney disease should be monitored carefully
  • Regular blood tests can monitor electrolyte levels
  • Other medications are more commonly associated with hyperkalemia
  • Consider the patient's overall clinical context when managing potential hyperkalemia.

References

Research

Diagnosis and treatment of hyperkalemia.

Cleveland Clinic journal of medicine, 2017

Research

Hyperkalemia: pathophysiology, risk factors and consequences.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.